THE EFFECT OF RENAL-FUNCTION ON ENALAPRIL KINETICS

被引：43

作者：

LOWENTHAL, DT

IRVIN, JD

MERRILL, D

SARIS, S

ULM, E

GOLDSTEIN, S

HICHENS, M

KLEIN, L

TILL, A

HARRIS, K

机构：

[1] HAHNEMANN UNIV,PHILADELPHIA,PA 19102

[2] MERCK SHARP & DOHME RES LABS,W POINT,PA 19486

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1985年 / 38卷 / 06期

关键词：

D O I：

10.1038/clpt.1985.242

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：661 / 666

页数：6

相关论文

共 15 条

[1] ANTIHYPERTENSIVE THERAPY WITH MK-421 - ANGIOTENSIN-II-RENIN RELATIONSHIPS TO EVALUATE EFFICACY OF CONVERTING ENZYME BLOCKADE [J].

BIOLLAZ, J ;

BRUNNER, HR ;

GAVRAS, I ;

WAEBER, B ;

GAVRAS, H .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1982, 4 (06) :966-972

[2] ENALAPRIL WORLDWIDE EXPERIENCE [J].

DAVIES, RO ;

IRVIN, JD ;

KRAMSCH, DK ;

WALKER, JF ;

MONCLOA, F .

AMERICAN JOURNAL OF MEDICINE, 1984, 77 (2A) :23-35

[3]

DICARLO L, 1982, CIRCULATION, V66, P209

[4] EFFECTS OF ENALAPRIL, A NEW CONVERTING ENZYME-INHIBITOR, IN HYPERTENSION [J].

FERGUSON, RK ;

VLASSES, PH ;

SWANSON, BN ;

MOJAVERIAN, P ;

HICHENS, M ;

IRVIN, JD ;

HUBER, PB .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 32 (01) :48-53

[5]

GAVRAS H, 1981, LANCET, V2, P543

[6]

GROSS DM, 1981, J PHARMACOL EXP THER, V216, P552

[7]

HICHENS M, 1981, Ligand Quarterly, V4, P43

[8]

IRVIN JD, 1984, CLIN PHARMACOL THER, V35, P248

[9]

LEVINE TB, 1982, CIRCULATION, V66, P209

[10]

LOWENTHAL DT, 1984, J HYPERTENSION S2, V2, P13